Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta - PubMed (original) (raw)
. 1999 Feb 15;59(4):872-9.
Affiliations
- PMID: 10029078
Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta
Z Dong et al. Cancer Res. 1999.
Abstract
We determined whether the IFN-beta gene can be used to suppress angiogenesis, tumor growth, and metastasis of human prostate cancer cells growing in the prostate of nude mice. Highly metastatic PC-3M human prostate cancer cells were engineered to constitutively produce murine IFN-beta subsequent to infection with a retroviral vector containing murine IFN-beta cDNA. Parental (PC-3M-P), control vector-transduced (PC-3M-Neo), and IFN-beta-transduced (PC-3M-IFN-beta) cells were injected into the prostate (orthotopic) or subcutis (ectopic) of nude mice. PC-3M-P and PC-3M-Neo cells produced rapidly growing tumors and regional lymph node metastases, whereas PC-3M-IFN-beta cells did not. PC-3M-IFN-beta cells also suppressed the tumorigenicity of bystander nontransduced prostate cancer cells. PC-3M-IFN-beta cells produced small tumors (3-5 mm in diameter) in nude mice treated with anti-asialo GM1 antibodies and in severe combined immunodeficient/Beige mice. Immunohistochemical staining revealed that PC-3M-IFN-beta tumors were homogeneously infiltrated by macrophages, whereas control tumors contained fewer macrophages at their periphery. Most tumor cells in the control tumors were stained positive by an antibody to proliferative cell nuclear antigen; very few were positively stained by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling. In sharp contrast, PC-3M-IFN-beta tumors contained fewer proliferative cell nuclear antigen-positive cells and many terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling-positive cells. Staining with antibody against CD31 showed that control tumors contained more blood vessels than PC-3M-IFN-beta tumors. PC-3M-IFN-beta cells were more sensitive to lysis mediated by natural killer cells in vitro or to cytostasis mediated by macrophages than control transduced cells. Conditioned medium from PC-3M-IFN-beta cells augmented splenic cell-mediated cytolysis to control tumor cells, which could be neutralized by antibody against IFN-beta. Collectively, the data suggest that the suppression of tumorigenicity and metastasis of PC-3M-IFN-beta cells is due to inhibition of angiogenesis and activation of host effector cells.
Similar articles
- Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP. Izawa JI, et al. Clin Cancer Res. 2002 Apr;8(4):1258-70. Clin Cancer Res. 2002. PMID: 11948141 - Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F, Lee J, Lu S, Pettaway CA, Dong Z. Zhang F, et al. Clin Cancer Res. 2005 Jun 15;11(12):4512-20. doi: 10.1158/1078-0432.CCR-04-2571. Clin Cancer Res. 2005. PMID: 15958637 - Regulation of neoplastic angiogenesis.
Fidler IJ. Fidler IJ. J Natl Cancer Inst Monogr. 2001;(28):10-4. doi: 10.1093/oxfordjournals.jncimonographs.a024251. J Natl Cancer Inst Monogr. 2001. PMID: 11158201 Review. - An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1.
Qin A. Qin A. Front Oncol. 2023 Apr 27;13:1173467. doi: 10.3389/fonc.2023.1173467. eCollection 2023. Front Oncol. 2023. PMID: 37182173 Free PMC article. Review.
Cited by
- Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.
Ren C, Kumar S, Chanda D, Kallman L, Chen J, Mountz JD, Ponnazhagan S. Ren C, et al. Gene Ther. 2008 Nov;15(21):1446-53. doi: 10.1038/gt.2008.101. Epub 2008 Jul 3. Gene Ther. 2008. PMID: 18596829 Free PMC article. - Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use.
Kim KY, Yi BR, Lee HR, Kang NH, Jeung EB, Kim SU, Choi KC. Kim KY, et al. Int J Oncol. 2012 Apr;40(4):1097-104. doi: 10.3892/ijo.2011.1288. Epub 2011 Dec 8. Int J Oncol. 2012. PMID: 22159640 Free PMC article. - The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model.
Yu J, Lee HJ, Hur K, Kwak MK, Han TS, Kim WH, Song SC, Yanagihara K, Yang HK. Yu J, et al. Invest New Drugs. 2012 Feb;30(1):1-7. doi: 10.1007/s10637-010-9499-y. Epub 2010 Jul 29. Invest New Drugs. 2012. PMID: 20669041 - Inhibition of tumor cell motility by the interferon-inducible GTPase MxA.
Mushinski JF, Nguyen P, Stevens LM, Khanna C, Lee S, Chung EJ, Lee MJ, Kim YS, Linehan WM, Horisberger MA, Trepel JB. Mushinski JF, et al. J Biol Chem. 2009 May 29;284(22):15206-14. doi: 10.1074/jbc.M806324200. Epub 2009 Mar 18. J Biol Chem. 2009. PMID: 19297326 Free PMC article. - Potential therapeutic strategies for lymphatic metastasis.
Zwaans BM, Bielenberg DR. Zwaans BM, et al. Microvasc Res. 2007 Sep-Nov;74(2-3):145-58. doi: 10.1016/j.mvr.2007.08.006. Epub 2007 Sep 19. Microvasc Res. 2007. PMID: 17950368 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical